Comparative mitochondrial proteomic analysis of raji cells exposed to adriamycin

Molecular Medicine

Volumn 15, Issue 5-6, 2009, Pages 173-182

  Jiang, Yu Jie ^a   Sun, Qing ^b   Fang, Xiao Sheng ^a   Wang, Xin ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B6; CARRIER PROTEIN; CELL CYCLE PROTEIN; DOXORUBICIN; HEAT SHOCK PROTEIN 70; MEMBRANE PROTEIN; PROHIBITIN; PROTEOME; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOINFORMATICS; CANCER RESISTANCE; CELL CYCLE REGULATION; CONTROLLED STUDY; DNA REPAIR; DOWN REGULATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; NONHODGKIN LYMPHOMA; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; RAJI CELL; UPREGULATION;

ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DOXORUBICIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, NON-HODGKIN; MITOCHONDRIA; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 66449107189     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2008.00129     Document Type: Article

References (51)

1. Multani P, White CA, Grillo-Lopez A. (2001) Non- Hodgkin's lymphoma: review of conventional treatments. Curr. Pharm. Biotechnol..2:279-91.
2. Armitage JO. (1993) Treatment of non-Hodgkin's lymphoma. N. Engl. J. Med..328:1023-30.
3. Parker SL, Tong T, Bolden S, Wingo PA. (1997) Cancer statistics. CA Cancer. J. Clin.47:5-27.
4. Patel S, Sprung AU, Keller BA, Heaton VJ, Fisher LM. (1997) Identification of yeast DNA topoiso- merase II mutants resistant to the antitumor drug doxorubicin: implications for the mechanisms of doxorubicin action and cytotoxicity. Mol. Pharmacol.52:658-66.
5. Singh V, Singh SM. (2007) Effect of high cell density on the growth properties of tumor cells: a role in tumor cytotoxicity of chemotherapeutic drugs. Anticancer Drugs18:1123-32.
6. Gunter TE, Gunter KK, Sheu SS, Gavin CE. (1994) Mitochondrial calcium transport: physiological and pathological relevance. Am. J. Physiol.267:C313-39.
7. Gunter TE, Buntinas L, Sparagna GC, Gunter KK. (1998) The Ca2+ transport mechanisms of mitochondria and Ca2+ uptake from physiological-type Ca2+ transients. Biochim. Biophys. Acta1366:5-15.
8. Goffart S, Martinsson P, Malka F, Rojo M, Spel- brink JN. (2007) The mitochondria of cultured mammalian cells; II: expression and visualization of exogenous proteins in fixed and live cells. Methods Mol. Biol.372:17-32.
9. Rorbach J, Soleimanpour-Lichaei R, Lightowlers RN, Chrzanowska- Lightowlers ZM. (2007) How do mammalian mitochondria synthesize proteins? Biochem. Soc. Trans.35:1290-1.
10. de Cavanagh EM, Inserra F, Ferder M, Ferder L. (2007) From mitochondria to disease: role of the renin-angiotensin system. Am. J. Nephrol.27:545- 53.
11. Schleicher E, Friess U. (2007) Oxidative stress, AGE, and atherosclerosis. Kidney Int. Suppl.S17-26.
12. Huang MQ, et al.(2007) In vivo monitoring response to chemotherapy of human diffuse large B-cell lymphoma xenografts in SCID mice by 1H and 31P MRS. Acad. Radiol.14:1531-9.
13. Vaisheva F, Delbes G, Hales BF, Robaire B. (2007) Effects of the chemotherapeutic agents for non- Hodgkin lymphoma, cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), on the male rat reproductive system and progeny outcome. J. Androl.28:578-87.
14. Wilson WH, et al.(1997) Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin s lymphomas. Blood.89:601-9.
15. Litvinova E, Gurova K, Chimishkian K, Mentke- vich G. (1999) Effects of CSFS and their combinations with chemotherapeutic agents (CH) on leukemic blasts (LB) in children (MTT-assay). Adv. Exp. Med. Biol.457:585-92.
16. Nikitin A, Egorov S, Daraselia N, Mazo I. (2003) Pathway studio-the analysis and navigation of molecular networks. Bioinformatics19:2155-7.
17. Rezaul K, Wu L, Mayya V, Hwang SI, Han D. (2005) A systematic characterization of mitochondrial proteome from human T leukemia cells. Mol. Cell. Proteomics4:169-81.
18. Zhu K, Zhao J, Lubman DM, Miller FR, Barder TJ. (2005) Protein pI shifts due to posttransla- tional modifications in the separation and characterization of proteins. Anal. Chem.77:2745-55.
19. Lee YH, Boelsterli UA, Lin Q, Chung MC. (2008) Proteomics profiling of hepatic mitochondria in heterozygous Sod2+/- mice, an animal model of discreet mitochondrial oxidative stress. Proteomics8:555-68.
20. Hoye AT, Davoren JE, Wipf P, Fink MP, Kagan VE. (2008) Targeting mitochondria. Acc. Chem. Res.41:87-97.
21. Ishii N. (2007) Role of oxidative stress from mitochondria on aging and cancer. Cornea26:S3-9.
22. Orrenius S. (2007) Reactive oxygen species in mitochondria-mediated cell death. Drug Metab. Rev.39:443-55.
23. Major T, von Janowsky B, Ruppert T, Mogk A, Voos W. (2006) Proteomic analysis of mitochon- drial protein turnover: identification of novel substrate proteins of the matrix protease pim1. Mol. Cell. Biol.26:762-76.
24. Green DR, Reed JC. (1998) Mitochondria and apoptosis. Science281:1309-12.
25. Bernardi P, Scorrano L, Colonna R, Petronilli V, Di Lisa F. (1999) Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur. J. Biochem.264:687-701.
26. Susin SA, et al.(1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature397:441-6.
27. Nemoto S, Takeda K, Yu ZX, Ferrans VJ, Finkel T. (2000) Role for mitochondrial oxidants as regulators of cellular metabolism. Mol. Cell. Biol.20:7311-8.
28. Beltran B, et al.(2002) Inhibition of mitochondrial respiration by endogenous nitric oxide: a critical step in Fas signaling. Proc. Natl. Acad. Sci. U. S. A.99:8892-7.
29. Douette P, Sluse FE. (2006) Mitochondrial uncoupling proteins: new insights from functional and proteomic studies. Free Radic. Biol. Med.. 40:1097-107.
30. Yang YX, Hu HD, Zhang DZ, Ren H. (2007) Identification of proteins responsible for the development of adriamycin resistance in human gastric cancer cells using comparative proteomics analysis. J. Biochem. Mol. Biol.40:853-60.
31. Kim SY, et al.(2006) Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes. Exp. Mol. Med.38:535-45.
32. Wonders KY, Hydock DS, Schneider CM, Hay-ward R. (2008) Acute exercise protects against doxorubicin cardiotoxicity. Integr. Cancer Ther.7:147-54.
33. Chandra J, Samali A, Orrenius S. (2000) Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med.. 29:323-33.
34. Yu Y, et al.(2007) Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells. J. Proteome Res.6:3808-18.
35. Ciocca DR, Calderwood SK. (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones.10:86-103.
36. Mizzen LA, Kabiling AN, Welch WJ. (1991) The two mammalian mitochondrial stress proteins, grp 75 and hsp 58, transiently interact with newly synthesized mitochondrial proteins. Cell Regul.2:165-79.
37. Voos W, Rottgers K. (2002) Molecular chaperones as essential mediators of mitochondrial biogenesis. Biochim. Biophys. Acta1592:51-62.
38. Werninghaus K, Handjani RM, Gilchrest BA. (1991) Protective effect of alpha-tocopherol in carrier liposomes on ultraviolet-mediated human epidermal cell damage in vitro. Photodermatol. Photoimmunol. Photomed.8:236-42.
39. Samali A, Orrenius S. (1998) Heat shock proteins: regulators of stress response and apoptosis. Cell Stress Chaperones3:228-36.
40. Perry ME, Dang CV, Hockenbery D, Moll U. (2004) Highlights of the National Cancer Institute Workshop on mitochondrial function and cancer. Cancer Res.64:7640-4.
41. Schmitt E, et al.(2006) Heat shock protein 70 neutralization exerts potent antitumor effects in animal models of colon cancer and melanoma. Cancer Res.66:4191-7.
42. Krishnamurthy PC, et al.(2006) Identification of a mammalian mitochondrial porphyrin transporter. Nature443:586-9.
43. Mitsuhashi N, et al.(2000) MTABC3, a novel mitochondrial ATP-binding cassette protein involved in iron homeostasis. J. Biol. Chem.275:17536-40.
44. Desmard M, Boczkowski J, Poderoso J, Motterlini R. (2007) Mitochondrial and cellular heme-dependent proteins as targets for the bioactive function of the heme oxygenase/carbon monoxide system. Antioxid. Redox. Signal9:2139-55.
45. Szakacs G, et al.(2004) Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells. Cancer Cell6:129-37.
46. Emadi-Konjin HP, et al.(2002) Isolation of a genomic clone containing the promoter region of the human ATP binding cassette (ABC) transporter, ABCB6. Biochim. Biophys. Acta1574:117-30.
47. Chen JC, Jiang CZ, Reid MS. (2005) Silencing a prohibitin alters plant development and senescence. Plant J.44:16-24.
48. Theiss AL, et al.(2007) Prohibitin protects against oxidative stress in intestinal epithelial cells. FASEB J.21:197-206.
49. Chowdhury I, et al.(2007) Apoptosis of rat granulosa cells after staurosporine and serum withdrawal is suppressed by adenovirus-directed overexpression of prohibitin. Endocrinology148:206-17.
50. Fusaro G, Wang S, Chellappan S. (2002) Differential regulation of Rb family proteins and pro- hibitin during camptothecin-induced apoptosis. Oncogene21:4539-48.
51. Choi D, Lee SJ, Hong S, Kim IH, Kang S. (2008) Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways. Oncogene27:1716-25.